AI assistant
Pacira BioSciences, Inc. — Director's Dealing 2011
Feb 10, 2011
32125_dirs_2011-02-10_8f22d239-2efe-44fe-9180-1a212229242b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Pacira Pharmaceuticals, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2011-02-10
Reporting Person: Sanderling Venture Partners VI LP (10% Owner)
Reporting Person: Sanderling Ventures Management VI (10% Owner)
Reporting Person: Sanderling VI Beteiligungs GmbH & Co KG (10% Owner)
Reporting Person: Sanderling VI Limited Partnership (10% Owner)
Reporting Person: Sanderling Venture Partners VI Co Investment Fund LP (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-02-08 | Common Stock | P | 27931 | $7 | Acquired | 27931 | Direct |
| 2011-02-08 | Common Stock | P | 4297 | $7 | Acquired | 4297 | Direct |
| 2011-02-08 | Common Stock | P | 5119 | $7 | Acquired | 5119 | Direct |
| 2011-02-08 | Common Stock | P | 184131 | $7 | Acquired | 184131 | Direct |
Footnotes
F2: The securities are held by Sanderling Ventures Management VI.
F3: The securities are held by Sanderling VI Beteiligungs GmbH & Co. KG.
F4: The securities are held by Sanderling VI Limited Partnership.
F6: The securities are held by Sanderling Venture Partners VI Co-Investment Fund.